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Secondary bile acids produced by the action of the colonic microﬂora may increase risk of colorectal cancer. Serum bile acid
concentrations reﬂect the faecal bile acid proﬁle and may be of value as biomarkers of risk of colorectal cancer. In a pilot
investigation we examined: (i) the reproducibility of measurements of serum bile acids in two blood samples collected several
years apart; and (ii) the hypothesis that relatively high levels of secondary bile acids, particularly deoxycholic acid, would be
positively associated with an increased risk of colorectal cancer in a prospective study of 3680 women in Guernsey. There was
poor reproducibility between repeat measurements of absolute serum concentrations of bile acids, but there was moderately
good reproducibility for the ratios of serum concentrations of deoxycholic/cholic acid, lithocholic/chenodeoxycholic and
secondary/primary bile acid concentrations (duplicate blood samples were available for 30 women). There were no signiﬁcant
differences in ratios of serum secondary to primary bile acids or in absolute concentrations of bile acids between the 46
women who developed colorectal cancer and their matched controls, although there was a suggestion that an increased risk
was associated with a high ratio of deoxycholic/cholic acid (relative risk in top third compared to lower third=3.92 (95% CI
0.91-17.0, P for trend=0.096). These ﬁndings suggest that the ratios of serum bile acid concentrations are sufﬁciently
reproducible for epidemiological studies, but that a larger study than our own is needed to adequately test the hypothesis of
their relation to cancer risk.
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Secondary bile acids may be involved in the aetiology of colon
cancer (Hill et al, 1971; Owen, 1997). The primary bile acids cholic
acid (CA) and chenodeoxycholic acid (CDCA) can be converted by
intestinal bacteria to form the secondary bile acids deoxycholic acid
(DCA) and lithocholic acid (LCA) respectively. LCA can undergo
further degradation to form ursodeoxycholic acid (UDCA).
Secondary bile acids have been found to be mutagenic and to
promote tumour growth in animal models, and the faeces of popu-
lations with a low risk of colonic cancer contain relatively low
proportions of secondary bile acids (Kishida et al, 1997). The
fermentation of carbohydrates within the colon results in the
production of short chain fatty acids which decrease colonic pH
and cause a subsequent decrease in the production of secondary
bile acids (Reddy et al, 1998). Bile acids are secreted from the gall
bladder in response to food intake, especially following fatty meals,
and most are reabsorbed from the colon. The serum bile acid
proﬁle has been proposed as an index of the intestinal bile acid
proﬁle (van Faassen et al, 1997). This study had two objectives:
ﬁrst, to test the reproducibility of measurements of bile acids in
stored serum; second, to investigate the association of these vari-
ables with risk of colorectal cancer in a pilot prospective nested
case-control study in women.
MATERIALS AND METHODS
Subjects
Between 1977 and 1990, 6127 women aged 534 years who lived
on the island of Guernsey in the English Channel were recruited
into a prospective study aimed principally at investigating hormo-
nal determinants of breast cancer risk. Recruitment was in two
phases, from 1977 to 1985 and from 1986 to 1991; 3680 women
participated in both recruitment phases. Participants completed a
questionnaire at interview, height and weight were measured, and
a blood sample was taken. Serum was stored in 2 ml aliquots at
7208C.
Follow-up for the diagnosis of cancer was by means of pathol-
ogy reports (all dealt with by one pathology laboratory),
Guernsey death certiﬁcates and the Wessex Cancer Registry (this
registry covers Southampton where some patients from Guernsey
are referred for hospital treatment). Cases were women diagnosed
with cancer of the colon or rectum subsequent to recruitment up
to the end of June 1999. For each case of colorectal cancer, a
control was selected at random, matched on age at and date
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www.bjcancer.comof blood collection (both within one year). Potential cases and
controls were not eligible if they had been diagnosed with any
other type of cancer before blood collection (except non-melano-
ma skin cancer). Potential controls were also known to be alive
and free of cancer at the date of diagnosis of their matched case.
Additionally, for cases which had two blood samples collected
before being diagnosed with cancer, controls were selected to
also have two blood samples, the second collected within one
year of the date of collection of the second blood sample from
the case.
Laboratory methods
Serum bile acids were analysed by gas chromatography/mass spec-
troscopy on the samples in June–July 2000 as previously described
(Costarelli and Sanders, 2001) except that quantiﬁcation was
undertaken in selective ion monitoring mode by scanning for ions
M/z 194, 255, 268, 370, 372, and 460. Ions M/z 255, 268, 255, 370,
372 and 255 were used to quantify nordeoxycholic, cholic, deoxy-
cholic, chenodeoxycholic, lithocholic and ursodeoxycholic acids
respectively.
Statistical analysis
The individual bile acid values (CA, CDCA, DCA, LCA, and
UDCA) were log-transformed. We also calculated and analysed
the ratios of deoxycholic/cholic acid (DCA/CA), lithocholic/cheno-
deoxycholic (LCA/CDCA) and secondary/primary bile acids (SBA/
PBA, where SBA=DCA+LCA+UDCA and PBA=CA+CDCA).
Where repeat observations were available from the two phases of
recruitment, reproducibility of the individual bile acid concentra-
tions and of the ratios was assessed using the intraclass
correlation coefﬁcient. In all other analyses, data from the earlier
phase of recruitment were used where repeat observations were
available.
The associations between the bile acid variables and other
factors including age, body mass index, the use of drugs at
the time of blood collection, time of blood collection, parity,
current smoking, and current hormone exposure (taking the
oral contraceptive pill, hormone replacement therapy or other
hormone use) were examined. Analyses were restricted to the
controls, and a simple one-way analysis of variance was used
to test for differences in the bile acid variable means by cate-
gories of each factor in turn.
Associations between the bile acid variables and colorectal
cancer risk were examined using paired t-tests and logistic regres-
sion. Unconditional logistic regression was chosen in preference to
conditional logistic regression using the case-control matching in
order to make full use of the available data. The logistic regression
analyses were adjusted for age at blood collection (in eight cate-
gories: 35–39, 40–44, 45–49, 50–54, 55–59, 60–64, 65–69,
70 and over) and year of blood collection (in seven categories:
1977, 1978, 1979, 1980, 1981, 1982–84, 1986–91; no blood
collection took place in 1985–86). Each variable was divided into
thirds based on the values among controls, and odds ratios calcu-
lated for the middle and top tertiles compared with the lower
tertile. A test of linear trend was performed by assessing the
signiﬁcance of the odds ratios associated with a unit increase in
each of the variables. Statistical signiﬁcance was set at the 5%
level throughout.
RESULTS
There were 48 colorectal cancer/case-control pairs. Baseline charac-
teristics of cases and controls are shown in Table 1. The
characteristics of cases and controls were generally similar,
although most controls had their blood collected in mid-afternoon
whereas most cases had their blood collected in late afternoon
(Table 1) and a higher proportion of controls were exposed to
exogenous hormones at the time of blood collection (both
P50.05). There were no signiﬁcant differences in mean values of
body mass index, nor in the use of drugs at the time of blood
collection, smoking or parity.
Bile acid measurements were available for 91 women. There
were no measurements for two cases and three controls, and
LCA was not detectable for a further ﬁve cases and three controls.
Duplicate measurements of each bile acid variable were available
for up to 30 women who participated in both recruitment phases.
There was generally poor reproducibility of the individual bile
acids and the intraclass correlation coefﬁcients were as follows:
CA 0.00, CDCA 0.16, DCA 0.10, LCA 0.18, UDCA 0.00 (all NS,
not signiﬁcant). However, there was moderately good reproducibil-
ity for the bile acid ratios and the intraclass correlation coefﬁcients
were: DCA/CA 0.59 (P50.001), LCA/CDCA 0.51 (P50.01),
secondary/primary 0.57 (P50.001).
In controls, the bile acid ratios were higher among the ﬁve
current smokers than among the 29 known non-smokers. The
mean ratios for current smokers compared with non-smokers were:
DCA/CA 57.2 vs 31.4 (NS), LCA/CDCA 0.26 vs 0.13 (P50.05),
SBA/PBA 13.8 vs 6.2 (P50.01). Bile acid concentrations were
generally higher among the eight women with current hormone
exposure than among the 40 women who were not taking any
exogenous hormones. Geometric mean values for current hormone
exposure compared with non-exposure were: CA 0.35 vs 0.07,
CDCA 0.86 vs 0.27 (both P50.01), DCA 1.55 vs 1.71, LCA 0.029
vs 0.026, UDCA 0.024 vs 0.011 (each NS). The ratio DCA/CA
was signiﬁcantly lower for women with current hormone exposure
compared with non-exposure: means 10.6 vs 40.4 (P50.05). There
were no signiﬁcant differences in bile acid variables by categories of
age, body mass index, the use of drugs at the time of blood collec-
tion, time of blood collection, or parity.
Table 2 shows the mean bile acid concentrations and ratios
for cases and controls. Paired comparison t-tests showed no
statistically signiﬁcant differences between cases and controls.
Table 3 shows the odds ratios for colorectal cancer calculated
using logistic regression analysis adjusted for age and year of
blood collection. There is some suggestion that higher values
of the ratio DCA/CA are associated with increased risk for color-
ectal cancer, but none of the trends were statistically signiﬁcant
and the conﬁdence intervals were wide. The odds ratios for
DCA/CA in the middle and top thirds compared with the lower
third were 3.41 (95% conﬁdence interval 0.89-13.0) and 3.92
(0.91-17.0) respectively.
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Table 1 Baseline characteristics of women with colorectal cancer (cases)
and their controls
Characteristic Cases (n=48) Controls (n=48)
Mean (SD) age at blood collection 54.8 (10.8) 54.7 (10.6)
Mean (SD) body mass index (kg m
72) 25.6 (4.0) 25.5 (3.9)
Time of blood collection
Before 2 pm 8 (16.7%) 5 (10.4%)
2 pm–4 pm 16 (33.3%) 29 (60.4%)
After 4 pm 24 (50.0%) 14 (29.2%)
Taking drugs at blood collection
a 18 (39.1%) 24 (50.0%)
Current smoker
b 4 (11.8%) 5 (14.7%)
Parity
0–1 11 (22.9%) 14 (29.2%)
2 21 (43.8%) 19 (39.6%)
3 or more 16 (33.3%) 15 (31.2%)
Current hormone exposure
c 2 (4.2%) 8 (16.7%)
aData available for 46 cases only;
bdata available for 34 cases and 34 controls only;
ccontraceptive pill, hormone replacement therapy or other hormones.
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Reproducibility and factors related to serum bile acid
concentrations
Bile acids are relatively robust compounds and are stable to
long-term storage. Between assay variability is low (less than
5%) and consequently most of the variability is biological.
Exposure to oestrogenic hormones results in a decrease in total
bile acids and chenodeoxycholic acid pool size and an
increased bile saturation (Bennion et al, 1978). The absolute
concentration of serum bile acid also increases markedly post-
prandially and this could explain much of the variance
(Costarelli and Sanders, 2001). In contrast, the ratios of bile
acids showed moderately good reproducibility within subjects.
Among controls, current hormone exposure was associated with
higher concentrations of CA and CDCA, and a lower ratio
DCA/CA. Cigarette smoking was associated with higher ratios
of LCA/CDCA and SBA/PBA. The mechanism by which smok-
ing could inﬂuence bile acid proﬁle is uncertain but this
relationship was not associated with BMI. However, these asso-
ciations were based on very small numbers of exposed women
and may have arisen by chance.
Bile acids and colorectal cancer risk
A case-control study (Bayerdorffer et al, 1993) reported higher
serum DCA concentrations in men but not women with adeno-
mas compared with controls. A later study by this group
suggested that serum DCA concentrations were correlated with
the rates of colorectal mucosal proliferation (Ochsenkuhn et al,
1999). However, the high serum DCA concentrations in these
studies might be related to the disease process or to dietary modi-
ﬁcations made by the patients following their diagnosis. In the
present study, where serum bile acid concentrations were deter-
mined several years prior to the occurrence of cancer, serum
DCA concentrations were not found to be associated with risk
of colorectal cancer. Owen (1997) suggested that LCA may
promote carcinogenesis. Serum concentrations of free LCA were
very much lower than those of DCA and the bulk of LCA is
present in a sulphated form which was not measured by the
methodology employed in this study. Haines et al (2000) reported
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Table 2 Geometric mean bile acid concentrations (mmol l
71), and arithmetic means
of selected bile acid ratios, together with their 95% conﬁdence intervals, in women with
colorectal cancer (cases) and their controls
Cases (n=46) Controls (n=45)
Mean 95% CI Mean 95% CI
Cholic acid (CA) 0.082 (0.057–0.118) 0.097 (0.065–0.144)
Chenodeoxycholic acid (CDCA) 0.307 (0.228–0.413) 0.327 (0.234–0.459)
Deoxycholic acid (DCA) 1.73 (1.41–2.12) 1.68 (1.33–2.12)
Lithocholic acid (LCA) 0.029 (0.023–0.036) 0.020 (0.022–0.032)
Ursodeoxycholic acid (UDCA) 0.016 (0.010–0.027) 0.013 (0.008–0.022)
DCA/CA 35.9 (26.9–44.9) 35.1 (24.1–46.2)
LCA/CDCA 0.16 (0.12–0.19) 0.14 (0.11–0.17)
Secondary/Primary bile acids 7.50 (6.08–8.91) 7.46 (5.80–9.13)
Table 3 Odds ratio for serum bile acid variables and risk of colorectal cancer in women
Third Cases Controls OR (95% CI) P for trend
Cholic acid (CA) Lower 20 17 1.00
Middle 14 13 0.94 (0.31–2.83)
Top 12 15 0.77 (0.24–2.43) 0.663
Deoxycholic acid (DCA) Lower 21 14 1.00
Middle 13 17 0.37 (0.11–1.20)
Top 12 14 0.54 (0.18–1.66) 0.245
Chenodeoxycholic acid (CDCA) Lower 14 15 1.00
Middle 18 16 1.32 (0.41–4.24)
Top 14 14 1.63 (0.47–5.71) 0.443
Lithocholic acid (LCA) Lower 11 14 1.00
Middle 13 14 2.11 (0.51–8.76)
Top 17 14 2.00 (0.59–6.74) 0.304
Ursodeoxycholic acid (UDCA) Lower 13 15 1.00
Middle 13 15 0.84 (0.26–2.73)
Top 20 15 2.19 (0.68–7.04) 0.188
DCA/CA Lower 7 15 1.00
Middle 20 16 3.41 (0.89–13.0)
Top 19 14 3.92 (0.91–17.0) 0.096
LCA/CDCA Lower 10 15 1.00
Middle 12 13 1.76 (0.53–5.90)
Top 19 14 2.03 (0.61–6.71) 0.251
Secondary/Primary bile acids Lower 17 17 1.00
Middle 12 12 0.59 (0.16–2.20)
Top 12 13 0.70 (0.21–2.38) 0.605
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acid and colorectal cancer in which 51 left-side and eight right-
side cases aged 45–74 were each matched with three control
subjects. Statistical analyses using conditional logistic regression
showed no signiﬁcant differences between the left-sided cases
and controls for any of the concentrations of individual bile acids
or of the ratio of lithocholic acid to deoxycholic acid. A statisti-
cally signiﬁcant association of the presence of chenodeoxycholic
acid in the right-side cases compared with the controls was
observed with an odds ratio of 6.26 (95% conﬁdence interval
1.19–32.84). However, this ﬁnding was based on only eight cases
and was not a prior hypothesis. In the present study no clear
associations between serum bile acid concentrations or their ratios
and colorectal cancer risk could be discerned. A larger study is
needed to test the hypothesis adequately.
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